BenevolentAI Competitors and Similar CompaniesClear all

BenevolentAI's competitors and similar companies include LabGenius, SOM Biotech, Paige AI, Recursion Pharmaceuticals and Lantern Pharma.
BenevolentAI
BenevolentAI
BenevolentAI is a clinical-stage AI-enabled drug discovery company.
LabGenius
LabGenius
LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions.
SOM Biotech
SOM Biotech
SOM Biotech is a clinical-stage drug discovery and development company.
Paige AI
Paige AI
Paige AI is a company that develops computational technologies to transform the diagnosis treatment, and biomarker discovery for cancer.
Recursion Pharmaceuticals
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.
Lantern Pharma
Lantern Pharma
Lantern Pharma is a biotechnology company developing precision cancer drugs.
Founding Date
Founding Date
2013
Founding Date
2012
Founding Date
2009
Founding Date
2018
Founding Date
2013
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
London, GB HQ
Babraham, GB
Locations
London, GB HQ
London, GB
Locations
Barcelona, ES HQ
Cambridge, US
Locations
New York, US HQ
Locations
Salt Lake City, US HQ
Locations
Dallas, US HQ
Employees
Employees
180
Employees
681% increase
Employees
15
Employees
783% decrease
Employees
216
Employees
2257% increase
Valuation ($)
Valuation ($)
1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2 b
Valuation ($)
37.6 m

Financial

Revenue (est.)
Revenue (est.)
€7.3m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$58.8m (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
£5.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$45.2m (FY, 2024)
Cost of goods
$11.4m (FY, 2024)
Gross profit
Gross profit
€7.8m (FY, 2023)
Gross profit
(£5.5m) (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Gross profit
$13.6m (FY, 2024)
Gross profit
N/A
Net income
Net income
(€63.3m) (FY, 2023)
Net income
(£6.8m) (FY, 2023)
Net income
N/A
Net income
N/A
Net income
($463.7m) (FY, 2024)
Net income
($20.8m) (FY, 2024)

Funding

Latest funding round
Latest funding round
$ 90m (almost 6 years ago)
Latest funding round
$ 15m (over 4 years ago)
Latest funding round
$ 7.8m (over 6 years ago)
Latest funding round
$ 25m (over 4 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 305m
Total funding raised
$ 28.7m
Total funding raised
$ 10m
Total funding raised
$ 220m
Total funding raised
$ 437.1m
Total funding raised
$ 4.7m
For sources of this data, please see the company profile

View Company Profiles

LabGenius
HQ
London, GB
Employees
68↑ 1% increase

LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions.

View company
SOM Biotech
HQ
Barcelona, ES
Employees
15

SOM Biotech is a clinical-stage drug discovery and development company.

View company
Paige AI
HQ
New York, US
Employees
78↓ 3% decrease

Paige AI is a company that develops computational technologies to transform the diagnosis treatment, and biomarker discovery for cancer.

View company
Recursion Pharmaceuticals
HQ
Salt Lake City, US
Employees
216

Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.

View company